ICON plc

ICON plc is one of the world’s leading Clinical Research Organizations (CROs), providing outsourced clinical development, consulting, data management, and commercialization services to pharmaceutical, biotechnology, medical device, and government organizations. Founded in 1990 and headquartered in Dublin, Ireland, ICON operates in more than 100 countries and supports thousands of clinical development programs globally.

The company offers comprehensive services across every phase of drug development, including clinical trial design, patient recruitment, site management, decentralized clinical trials, biostatistics, data management, medical writing, pharmacovigilance, regulatory consulting, real-world evidence, and commercialization support. Through its acquisition of PRA Health Sciences, ICON significantly expanded its global capabilities and therapeutic expertise.

ICON leverages artificial intelligence, advanced analytics, decentralized trial technologies, electronic clinical outcome assessment (eCOA), and digital health solutions to improve trial efficiency and accelerate regulatory approvals. The company collaborates with leading pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare organizations to bring innovative therapies to market more efficiently.

With a strong commitment to scientific excellence, regulatory compliance, patient-centric research, and digital transformation, ICON has become one of the world’s most respected partners for global clinical research and development.